442 related articles for article (PubMed ID: 29086100)
1. Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.
Candotti F
J Clin Immunol; 2018 Jan; 38(1):13-27. PubMed ID: 29086100
[TBL] [Abstract][Full Text] [Related]
2. Current and emerging treatment options for Wiskott-Aldrich syndrome.
Worth AJ; Thrasher AJ
Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
[TBL] [Abstract][Full Text] [Related]
3. Wiskott-Aldrich syndrome; an x-linked primary immunodeficiency disease with unique and characteristic features.
Ariga T
Allergol Int; 2012 Jun; 61(2):183-9. PubMed ID: 22361515
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome.
Bosticardo M; Marangoni F; Aiuti A; Villa A; Grazia Roncarolo M
Blood; 2009 Jun; 113(25):6288-95. PubMed ID: 19351959
[TBL] [Abstract][Full Text] [Related]
5. [Wiskott-Aldrich syndrome].
Gulácsy V; Maródi L
Orv Hetil; 2008 Jul; 149(29):1367-71. PubMed ID: 18617469
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
7. The genotype of the original Wiskott phenotype.
Binder V; Albert MH; Kabus M; Bertone M; Meindl A; Belohradsky BH
N Engl J Med; 2006 Oct; 355(17):1790-3. PubMed ID: 17065640
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
Labrosse R; Chu JI; Armant MA; Everett JK; Pellin D; Kareddy N; Frelinger AL; Henderson LA; O'Connell AE; Biswas A; Coenen-van der Spek J; Miggelbrink A; Fiorini C; Adhikari H; Berry CC; Cantu VA; Fong J; Jaroslavsky J; Karadeniz DF; Li QZ; Reddy S; Roche AM; Zhu C; Whangbo JS; Dansereau C; Mackinnon B; Morris E; Koo SM; London WB; Baris S; Ozen A; Karakoc-Aydiner E; Despotovic JM; Forbes Satter LR; Saitoh A; Aizawa Y; King A; Nguyen MAT; Vu VDU; Snapper SB; Galy A; Notarangelo LD; Bushman FD; Williams DA; Pai SY
Blood; 2023 Oct; 142(15):1281-1296. PubMed ID: 37478401
[TBL] [Abstract][Full Text] [Related]
9. New insights into the biology of Wiskott-Aldrich syndrome (WAS).
Thrasher AJ
Hematology Am Soc Hematol Educ Program; 2009; ():132-8. PubMed ID: 20008191
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for the Wiskott-Aldrich syndrome.
Galy A; Thrasher AJ
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):545-50. PubMed ID: 21971332
[TBL] [Abstract][Full Text] [Related]
11. Wiskott-Aldrich syndrome.
Notarangelo LD; Miao CH; Ochs HD
Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
[TBL] [Abstract][Full Text] [Related]
12. Wiskott Aldrich Syndrome: A Multi-Institutional Experience From India.
Suri D; Rikhi R; Jindal AK; Rawat A; Sudhakar M; Vignesh P; Gupta A; Kaur A; Sharma J; Ahluwalia J; Bhatia P; Khadwal A; Raj R; Uppuluri R; Desai M; Taur P; Pandrowala AA; Gowri V; Madkaikar MR; Lashkari HP; Bhattad S; Kumar H; Verma S; Imai K; Nonoyama S; Ohara O; Chan KW; Lee PP; Lau YL; Singh S
Front Immunol; 2021; 12():627651. PubMed ID: 33936041
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel WAS mutation in a South African patient presenting with atypical Wiskott-Aldrich syndrome: a case report.
Glanzmann B; Möller M; Schoeman M; Urban M; van Helden PD; Frigati L; Grewal R; Pieters H; Loos B; Hoal EG; Glashoff RH; Cornelissen H; Rabie H; Esser MM; Kinnear CJ
BMC Med Genet; 2020 Jun; 21(1):124. PubMed ID: 32503528
[TBL] [Abstract][Full Text] [Related]
14. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.
Castiello MC; Scaramuzza S; Pala F; Ferrua F; Uva P; Brigida I; Sereni L; van der Burg M; Ottaviano G; Albert MH; Grazia Roncarolo M; Naldini L; Aiuti A; Villa A; Bosticardo M
J Allergy Clin Immunol; 2015 Sep; 136(3):692-702.e2. PubMed ID: 25792466
[TBL] [Abstract][Full Text] [Related]
15. The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function.
Blundell MP; Worth A; Bouma G; Thrasher AJ
Dis Markers; 2010; 29(3-4):157-75. PubMed ID: 21178275
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in our understanding of Wiskott-Aldrich syndrome.
Sullivan KE
Curr Opin Hematol; 1999 Jan; 6(1):8-14. PubMed ID: 9915548
[TBL] [Abstract][Full Text] [Related]
17. Novel WASP mutation in a patient with Wiskott-Aldrich syndrome: Case report and review of the literature.
Eghbali M; Sadeghi-Shabestari M; Najmi Varzaneh F; Zare Bidoki A; Rezaei N
Allergol Immunopathol (Madr); 2016; 44(5):450-4. PubMed ID: 26993433
[TBL] [Abstract][Full Text] [Related]
18. Clinical, Laboratory Features and Clinical Courses of Patients with Wiskott Aldrich Syndrome and X-linked Thrombocytopenia-A single center study.
Bildik HN; Cagdas D; Ozturk Kura A; Oskay Halacli S; Sanal O; Tezcan I
Immunol Invest; 2022 Jul; 51(5):1272-1283. PubMed ID: 34098853
[TBL] [Abstract][Full Text] [Related]
19. How I manage patients with Wiskott Aldrich syndrome.
Rivers E; Worth A; Thrasher AJ; Burns SO
Br J Haematol; 2019 May; 185(4):647-655. PubMed ID: 30864154
[TBL] [Abstract][Full Text] [Related]
20. A Novel Mutation Leading to Wiskott-Aldrich Syndrome in an Ethiopian Boy: a Case Report and a Review of Literature.
Alemayehu T; Vinh DC
J Clin Immunol; 2023 Aug; 43(6):1272-1277. PubMed ID: 37052865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]